Aurora Cannabis Inc. is building up inventory in anticipation of the legalization of edibles and vaping products next fall, but insists that won’t interrupt its sales growth and march to profitability. ARTICLE CONTINUES BELOWOttawa has indicated edibles containing cannabis and cannabis concentrates would become legal for consumers in October, but the exact timing of product approvals and sales is still unknown. On the conference call with financial analysts, he said Aurora’s growth in medical cannabis sales and patients in the three months ended March 31 should that fears of softening demand after retail sales were allowed were unfounded. Revenue from Canadian consumer sales rose 37 per cent to $29.6 million, exceeding medical revenue of $29.1 million, which was up 12 per cent as Aurora’s patient count rose five per cent. “In this phase of the sector’s development, I would say, absolutely, that the number one critical success factor is the ability to produce and sell an enormous volume of cannabis,” Battley said.

Source: thestar May 15, 2019 17:48 UTC